Life Science News

The Company recorded over $100k in revenue for the month of February alone, which overshoots the Company's previous all-time high in December of 2021 by 46%

Komo Plant Based Foods Inc. (CSE:YUM)(OTCQB:KOMOF)(FRA:9HB) ("Komo" or the "Company") a premium plant-based food company, is pleased to announce that it's February revenue catapulted to over $100k, a full 46% increase over Komo's previous best month of sales in December 2021

"We are extremely proud of the momentum that the brand is gaining, and we have been focused not only on driving immediate sales, but also on laying the foundation for sustainable growth by strategic expansion of our distribution network, and customer-centric new product development," said William White, CEO of Komo. "We have an aggressive expansion strategy that we are implementing for the U.S. retail market, while also continuing to expand our distribution throughout Canada."

Since shipping its first pallet to the Quebec and Ontario markets at the beginning of this year, the brand is now available for sale throughout Quebec and Ontario in 40 locations, with agreements signed for 60 additional distribution points. This includes mainstream grocery stores such as Metro in Quebec, Sobey's franchises such as Foodland in Ontario, and specialty natural food retailers throughout Ontario including Ambrosia and Fiesta Farms.

Komo also delivered its first order to GTFO It's Vegan, a major plant-based eCommerce platform that is bringing Komo's products to consumers across the U.S.

"Just one year ago, we launched in our home market of Vancouver, and now we are serving customers across North America," added White. "Our customers are at the heart of everything we do, and their feedback is an essential component of our product development process. This focus on the customer has paid off, and in less than one year, we have received over 200 verified five-star buyer reviews online."

The Company's gross profit margin was at 35% during the most recently reported quarter ended October 31, 2021. The Company anticipates its gross margin to decrease slightly, but remain healthy as the Company focuses more resources on expansion efforts through wholesale channels, which deliver lower margins, but enable the company to earn greater market share and achieve other economies of scale.

About Komo

Komo Plant Based Foods Inc. is a premium plant-based food company that believes plant-based eating is the future, and that change can start with a single bite™. The Company develops, manufactures and sells a variety of 100% plant-based, preservative-free, hearty, satisfying, and wholesome frozen meals under its operating subsidiary Komo Comfort Foods. The product line is focused on recreating vegan versions of traditionally cheesy and meaty comfort foods such as Lasagna, Shepherd's Pie, Chickenless Pot Pie, and a line of Plant-Based Meal HelpersTM. The Company's goal is to make plant-based meals a staple through feel-good food that connect people and planet. The products are sold direct-to-consumer via eCommerce, as well as in grocery, convenience, and natural retailers. The frozen meals have a 1-year shelf-life. Ready-to-eat meals are also available in Metro Vancouver through Uber Eats and Skip the Dishes.

Learn more at: www.komocomfortfoods.com and follow on Instagram: @komocomfortfoods

For further information, please contact:

William White, President & CEO, Komo Plant Based Foods Inc.will@komoeats.com
1-866-969-0882

The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.

Cautionary Statement Regarding Forward-Looking Statements

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or Komo's future performance. The use of any of the words "could", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward looking information and are based on Komo's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, Komo's product development plans, its ability to launch its products on food delivery apps, its ability to retain key personnel, its revenues, and its expectation as to the acceptance of its products by retailer stores and consumers constitute forward-looking information. Actual results and developments may differ materially from those contemplated by forward-looking information. Readers are cautioned not to place undue reliance on forward-looking information. The statements made in this press release are made as of the date hereof. Komo disclaims any intention or obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as may be expressly required by applicable securities laws.

SOURCE: Komo Plant Based Foods Inc.



View source version on accesswire.com:
https://www.accesswire.com/691990/Komo-Plant-Based-Foods-Monthly-Revenue-Hits-All-Time-High

News Provided by ACCESSWIRE via QuoteMedia

YUM:CC
Komo Plant-Based Foods

Komo Plant-Based Foods


Keep reading...Show less
Komo Plant-Based Foods Appoints US Sales Management Consultants

Komo Plant-Based Foods Appoints US Sales Management Consultants

Komo Plant Based Foods Inc. (CSE:YUM)(OTCQB:KOMOF)(FRA:9HB) ("Komo") is pleased to announce the appointment of a U.S. sales consultant, Caboodle Consulting LLC (Caboodle), to develop Komo's retail expansion throughout the United States. Komo will work closely with the Caboodle sales management team to build out the US retail strategy. Heather Barry Whittier will be representing Komo as the Director of Sales. Ms. Whittier has 20+ years experience in the natural products industry including a pivotal role in growing a brokerage, Yin Yang Naturals, from regional to national coverage

Other members of the Caboodle management team include Lisa Thorson and Constance Wolfe. Lisa Thorson comes from a Market Analysis background with 10+ years' experience in Consumer Packaged Goods (CPG) brokerage and brand management with experience at Laird Superfood and Alliance Sales & Marketing. Constance Wolfe offers 10+ years of brand management experience including specializing in data analysis and trade spend promotional management with experience at Coconut Bliss and Hilary's Eat Well.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Komo Plant Based Foods Inc. Establishes US Cold Storage Partnership

Komo Plant Based Foods Inc. Establishes US Cold Storage Partnership

Komo Plant Based Foods Inc. (CSE:YUM)(OTCQB:KOMOF)(FRA:9HB) ("Komo"), a premium plant-based food company, is pleased to announce it will be partnering with HLC Distributing as a third-party logistics (3PL) Warehouse for the U.S

"We are thrilled to work with Komo foods as they look to expand into the US market. They're an innovative company that understands the plant-based segment," said Alec Hendren, Vice President of HLC Distributing (HLC). "As a cold storage and logistics provider, we are excited to help provide the resources needed to get great products out into the market. It's the right fit for both companies and I look forward to building the relationship as we both grow."

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Komo Plant Based Foods Grows Distribution Across Quebec, Ontario, and Maritimes

Komo Plant Based Foods Grows Distribution Across Quebec, Ontario, and Maritimes

Komo Plant Based Foods Inc. (CSE:YUM) (OTCQB:KOMOF) (FRA:9HB) ("Komo"), a premium plant-based food company, is pleased to announce that Horizon Nature is now carrying all Komo frozen plant-based products for distribution, with a focus on Quebec and the Maritimes with a growing market in Ontario

Horizon Nature is a full service distributor to natural, independent and grocery banners. Founded in 2003, the company is still a Quebec family owned business today. Operating from a vast and modern distribution centre in St-Léonard, Horizon Nature offers a wide variety of local, national and global brands supported by an experienced sales team. As a supplier to Metro, Provigo, Tau and Avril, they offer a range of products spanning from fresh to dry grocery and frozen, with an emphasis on healthy whole foods as well as products across various dietary needs, whether gluten free or vegan ingredients and meals.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Komo Plant Based Foods Shares Canadian Retail Update

Komo Plant Based Foods Shares Canadian Retail Update

Komo Plant Based Foods Inc. (CSE:YUM) (OTCQB:KOMOF) (FRA:9HB) ("Komo"), a premium plant-based food company, is pleased to announce it's now being carried in a total of 240 distribution points across Canada; 39 of which are in Eastern Canada

According to a 2020 Statista Report there are 2.3 million vegetarians in Canada and an additional 850,000 classified themselves as vegan. Research conducted by the Angus Reid Institute (Canadian non-profit independent research organization) has found that 1 in 5 Canadians (22%) who regularly eat meat would like to reduce the amount of meat they consume. In eastern Canada, which has a population of 14 million, people spend an average of $10,418 per year on food. Source: https://www.statista.com/statistics/567888/average-annual-household-expenditures-in-ontario-canada/

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Komo Plant Based Foods Launches in Whole Foods Market Retail Locations in Western Canada

Komo Plant Based Foods Launches in Whole Foods Market Retail Locations in Western Canada

Komo Plant Based Foods Inc. (CSE:YUM) (OTCQB: KOMOF) (FRA:9HB) ("Komo"), a premium plant-based food company, is pleased to announce it's now being carried in 4 out of 7 western Whole Foods Market locations

Whole Foods Market, Inc. is an American multinational supermarketchain headquartered in Austin, Texas, which sells organic foods and products free from hydrogenated fats and artificial colors, flavors, and preservatives. Whole Foods seeks out the finest natural and organic foods available, maintains the strictest quality standards in the industry, and has an unshakeable commitment to sustainable agriculture. Whole Foods has more than 500 retail and non-retail locations in the US, Canada and the United Kingdom. It has 14 retail locations in Canada, of which 7 are in British Columbia, and 7 are in Ontario. In 2017, Amazon purchased Whole Foods Market for USD$13.7 Billion.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

U.S. FDA Approves Bristol Myers Squibb's CAR T Cell Therapy Breyanzi® for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy

I n the pivotal Phase 3 TRANSFORM trial, single infusion of Breyanzi significantly outperformed the nearly 30-year standard of care with median event-free survival of 10.1 months vs. 2.3 months and a well-established safety profile

Approval was also based on data from the Phase 2 PILOT study, the first and only company-sponsored study of a CAR T cell therapy in patients with primary refractory or relapsed LBCL who are not considered candidates for transplant, in which Breyanzi delivered deep and durable responses

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

U.S. FDA Approves Bristol Myers Squibb's CAR T Cell Therapy Breyanzi® for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy

I n the pivotal Phase 3 TRANSFORM trial, single infusion of Breyanzi significantly outperformed the nearly 30-year standard of care with median event-free survival of 10.1 months vs. 2.3 months and a well-established safety profile

Approval was also based on data from the Phase 2 PILOT study, the first and only company-sponsored study of a CAR T cell therapy in patients with primary refractory or relapsed LBCL who are not considered candidates for transplant, in which Breyanzi delivered deep and durable responses

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Bristol Myers Squibb Presents New Data Showing Effect of Early Zeposia Treatment in Improving and Preserving Cognitive Function in People With Relapsing Multiple Sclerosis

Results showed improved or preserved cognitive function in a majority of people regardless of baseline values, with the greatest effect observed in almost 80% of people with high thalamic volume (45.5% improved and 34.1% preserved) at Month 48 of the DAYBREAK open-label extension trial

Zeposia was well tolerated, with more than 80% of people staying on therapy through 48 months

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

New Data Highlight Immune Response to COVID-19 Vaccines in Individuals with Relapsing Forms of Multiple Sclerosis Treated with Zeposia

Analysis of ongoing DAYBREAK open-label extension trial of Zeposia showed that seroconversion occurred in 100% of those treated with mRNA vaccines and in a majority of those treated with non-mRNA vaccines

New analyses to be featured in late-breaking research session at the 8th European Academy of Neurology Congress in Vienna, Austria

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
BriaCell Anti-Cancer Technology Published in Leading Cancer Drug Discovery Journal

BriaCell Anti-Cancer Technology Published in Leading Cancer Drug Discovery Journal

  • Anti-Cancer activity of BriaCell's lead candidate, Bria-IMT™, in advanced breast cancer patients was published in a leading peer-reviewed publication.
  • Bria-IMT™, through a novel mechanism of action, rapidly destroyed tumors in patients who matched Bria-IMT™ HLA types, supporting BriaCell's platform strategy of developing off-the-shelf personalized immunotherapy for multiple cancer indications.
  • The clinical data, previously reported, included rapid tumor reduction and extended survival.

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell" or the "Company") a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer, is pleased to announce the publication of novel scientific data and clinical data (previously reported) on BriaCell's lead candidate, Bria-IMT™. The abstract of the paper was published on-line in Recent Patents on Anti-Cancer Drug Discovery a publication focused on research (where patents have been registered) in leading therapeutic areas, targets, and agents related to anti-cancer drug discovery. The publication highlights BriaCell's approach to developing novel cellular immunotherapies for cancer and the safety and efficacy of Bria-IMT™ against advanced breast cancer in a prior clinical study through a potentially unique mechanism of action. The full text of the article will be made available.

"We are thrilled to see the congruence of our scientific insights and the clinical activity of our immunotherapy in advanced breast cancer patients," stated Dr. Williams, BriaCell's President & CEO. "This paper highlights our findings of rapid tumor shrinkage in multiple anatomic locations including difficult to treat sites like the brain. We are even more excited to see the potential positive effect on survival in these patients. Having these scientific and clinical findings published in such a highly regarded journal is a significant achievement for BriaCell. The results support our approach for selecting patients most likely to benefit from our immunotherapy. This undergirds our current strategy of building a pipeline of off-the-shelf personalized immunotherapies as potentially safe and effective treatments for advanced breast cancer and other cancers," Dr. Williams added.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Investigational Lenacapavir Receives Positive CHMP Opinion for People With Multi-Drug Resistant HIV

Recommendation is Based on Week 26 Data from the CAPELLA Trial Showing Twice-Yearly Lenacapavir Achieved High Rates of Virologic Suppression in Heavily Treatment-Experienced People with HIV –

– If Authorized, Lenacapavir Could Offer a New, Every Six-Month Treatment Option for People with Limited Treatment Choices

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×